NorthWest Biotherapeutics Inc (NWBO)

[jammyjames]

to compare the info arm to the main trial as objectively as possible I tried reverse engineering the combined info arm KM curve. There may be more up to date information or maybe i made a mistake but this is what i got (blue dots are censors):



The data I used was old data from presentation slides of the info arm patients for which there was data that i could read off a bar chart.

Rapid progressors:
I used survival months of 7,8,8.5,9,9,9.5,10.5,10.5,14,15,15.5,16.5,17.5,18.5,19.5,20,20,22,31
and one censor at 42 months (still alive)

from:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=120569800

confirmed pseudoprogressor:
censored at 30.1 months (still alive)

indeterminate:
9,10.5,11.5,12.5,13,14,15,16,18,19,19.5,19.5,22,22,30,35,36,42
censors of 55,55 and 60.5, 61, 65,66 (still alive) and 35 (LTFU)

from:

https://smithonstocks.com/northwest-biotherapeutics-why-i-believe-that-the-phase-3-trial-of-dcvax-l-in-newly-diagnosed-glioblastoma-patients-has-a-very-good-chance-for-success-nwbo-buy-0-17/

The unclassified patients:
OS of <9,2months, <9.2months (these two I just set at 9.1 months), 9.2months and 30.1 months. Another patient we do not know the OS except that it’s over 9.2months so I just used a censor at 9.2 months.

from:

https://nwbio.com/nw-bio-reports-promising-survival-data-51-gbm-patients-treated-dcvax-l/